• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有佐剂特性的纳米颗粒/微颗粒输送载体的性质和应用,适用于口服疫苗接种。

Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.

机构信息

College of Life Sciences, Fujian Normal University, Fuzhou, China.

State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, China.

出版信息

Int J Nanomedicine. 2018 May 21;13:2973-2987. doi: 10.2147/IJN.S154743. eCollection 2018.

DOI:10.2147/IJN.S154743
PMID:29861631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5968786/
Abstract

Vaccination is one of the most effective approaches in the prevention and control of disease worldwide. Oral vaccination could have wide applications if effective protection cannot be achieved through traditional (eg, parenteral) routes of vaccination. However, oral administration is hampered by the difficulties in transferring vaccines in vivo. This has led to the development of materials such as carriers with potential adjuvant effects. Considering the requirements for selecting adjuvants for oral vaccines as well as the advantages of nanoparticle/microparticle materials as immune effectors and antigen conveyors, synthetic materials could improve the efficiency of oral vaccination. In this review, nanoparticles and microparticles with adjuvant characteristics are described with regard to their potential importance for oral immunization, and some promising and successful modification strategies are summarized.

摘要

疫苗接种是全球疾病预防和控制最有效的方法之一。如果无法通过传统(例如,肠胃外)疫苗接种途径实现有效保护,口服疫苗接种可能具有广泛的应用。然而,口服给药受到将疫苗在体内传递的困难的阻碍。这导致了具有潜在佐剂作用的载体等材料的发展。考虑到选择口服疫苗佐剂的要求以及纳米颗粒/微粒材料作为免疫效应物和抗原载体的优势,合成材料可以提高口服疫苗接种的效率。在这篇综述中,描述了具有佐剂特性的纳米颗粒和微粒,因为它们对口免疫接种具有潜在的重要性,并总结了一些有前途且成功的修饰策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/6cf97d6bde45/ijn-13-2973Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/362dedd64daf/ijn-13-2973Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/ccbfbfaaf441/ijn-13-2973Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/c220ce8ca359/ijn-13-2973Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/6a991ef6e041/ijn-13-2973Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/9b266d1474cf/ijn-13-2973Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/4829dfdff36e/ijn-13-2973Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/6cf97d6bde45/ijn-13-2973Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/362dedd64daf/ijn-13-2973Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/ccbfbfaaf441/ijn-13-2973Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/c220ce8ca359/ijn-13-2973Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/6a991ef6e041/ijn-13-2973Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/9b266d1474cf/ijn-13-2973Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/4829dfdff36e/ijn-13-2973Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da21/5968786/6cf97d6bde45/ijn-13-2973Fig7.jpg

相似文献

1
Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.具有佐剂特性的纳米颗粒/微颗粒输送载体的性质和应用,适用于口服疫苗接种。
Int J Nanomedicine. 2018 May 21;13:2973-2987. doi: 10.2147/IJN.S154743. eCollection 2018.
2
Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.用于制备针对传染病的抗体和疫苗的金纳米颗粒。
Expert Rev Vaccines. 2020 May;19(5):465-477. doi: 10.1080/14760584.2020.1758070. Epub 2020 Apr 28.
3
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.黏膜免疫中可生物降解纳米颗粒佐剂效应的作用机制研究。
J Control Release. 2009 Sep 1;138(2):113-21. doi: 10.1016/j.jconrel.2009.05.011. Epub 2009 May 13.
4
Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.开发纳米颗粒佐剂以增强对白喉类毒素的免疫反应。
Hum Antibodies. 2018 Feb 5;26(2):75-85. doi: 10.3233/HAB-170324.
5
Chemical adjuvants for plasmid DNA vaccines.用于质粒DNA疫苗的化学佐剂。
Vaccine. 2007 May 10;25(19):3731-41. doi: 10.1016/j.vaccine.2007.01.120. Epub 2007 Feb 20.
6
Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens.CpG-ODN 负载的中空聚合物纳米颗粒诱导抗病毒和疫苗应用中的鸡体产生强大免疫反应。
Int J Nanomedicine. 2020 May 11;15:3303-3318. doi: 10.2147/IJN.S241492. eCollection 2020.
7
Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.多孔硅纳米粒子作为口服疫苗佐剂增强黏膜和全身免疫应答:硅石结构对免疫特性的影响。
Int J Pharm. 2012 Oct 15;436(1-2):351-8. doi: 10.1016/j.ijpharm.2012.06.028. Epub 2012 Jun 18.
8
Recent advances in vaccine adjuvants for systemic and mucosal administration.用于全身和黏膜给药的疫苗佐剂的最新进展
J Pharm Pharmacol. 1998 Jan;50(1):1-10. doi: 10.1111/j.2042-7158.1998.tb03298.x.
9
New insights in mucosal vaccine development.黏膜疫苗研发的新视角。
Vaccine. 2012 Jan 5;30(2):142-54. doi: 10.1016/j.vaccine.2011.11.003. Epub 2011 Nov 12.
10
New developments in nanoparticle-based vaccination.基于纳米颗粒的疫苗接种新进展。
Hum Vaccin Immunother. 2013 Dec;9(12):2502.

引用本文的文献

1
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines.用于现代疫苗的基于纳米颗粒的佐剂和递送系统。
Vaccines (Basel). 2023 Jun 29;11(7):1172. doi: 10.3390/vaccines11071172.
2
Manufacture of Mesoporous Silicon Microparticles (MSMPs) as Adjuvants for Vaccine Delivery.介孔硅微球(MSMPs)作为疫苗传递佐剂的制备。
Methods Mol Biol. 2023;2673:123-130. doi: 10.1007/978-1-0716-3239-0_8.
3
An update on oral drug delivery intestinal lymphatic transport.口服药物递送的肠道淋巴转运最新进展。

本文引用的文献

1
Peptide nanofiber-CaCO composite microparticles as adjuvant-free oral vaccine delivery vehicles.肽纳米纤维-碳酸钙复合微粒作为无佐剂口服疫苗递送载体
J Mater Chem B. 2016 Mar 7;4(9):1640-1649. doi: 10.1039/c5tb01623a. Epub 2015 Oct 29.
2
Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.经鼻腔途径增强 ROP18 疫苗对慢性弓形虫病的保护效力。
Med Microbiol Immunol. 2017 Feb;206(1):53-62. doi: 10.1007/s00430-016-0483-9. Epub 2016 Oct 18.
3
Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.
Acta Pharm Sin B. 2021 Aug;11(8):2449-2468. doi: 10.1016/j.apsb.2020.12.022. Epub 2021 Apr 9.
4
Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases.纳米和微粒作为针对传染病的潜在口服疫苗载体和佐剂
Front Pharmacol. 2021 Jun 2;12:682286. doi: 10.3389/fphar.2021.682286. eCollection 2021.
5
pH-Controlled Release of Antigens Using Mesoporous Silica Nanoparticles Delivery System for Developing a Fish Oral Vaccine.利用介孔硅纳米粒子递送系统控制 pH 释放抗原用于开发鱼类口服疫苗。
Front Immunol. 2021 Apr 19;12:644396. doi: 10.3389/fimmu.2021.644396. eCollection 2021.
6
Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy.免疫检查点阻断治疗的分子谱与年龄相关的差异。
Front Immunol. 2021 Apr 15;12:657575. doi: 10.3389/fimmu.2021.657575. eCollection 2021.
7
Smart Targeting To Improve Cancer Therapeutics.智能靶向以改善癌症治疗
Drug Des Devel Ther. 2019 Oct 30;13:3753-3772. doi: 10.2147/DDDT.S219489. eCollection 2019.
8
Formulation technologies for oral vaccines.口服疫苗的制剂技术。
Clin Exp Immunol. 2019 Nov;198(2):153-169. doi: 10.1111/cei.13352. Epub 2019 Aug 8.
9
Mucosal vaccines and technology.黏膜疫苗和技术。
Clin Exp Immunol. 2019 May;196(2):205-214. doi: 10.1111/cei.13285. Epub 2019 Apr 8.
10
DNA Vaccines-How Far From Clinical Use?DNA 疫苗——距离临床应用还有多远?
Int J Mol Sci. 2018 Nov 15;19(11):3605. doi: 10.3390/ijms19113605.
多层工程化纳米脂质体作为一种用于口服递送抗A组链球菌脂肽疫苗的新型工具。
Nanomedicine (Lond). 2016 May;11(10):1223-36. doi: 10.2217/nnm.16.36. Epub 2016 Apr 14.
4
Bilosomes in the context of oral immunization: development, challenges and opportunities.口腔免疫中的双分子层脂质体:发展、挑战与机遇
Drug Discov Today. 2016 Jun;21(6):888-99. doi: 10.1016/j.drudis.2016.03.013. Epub 2016 Mar 30.
5
Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.在小鼠模型中,口服合成硒纳米颗粒在乙肝表面抗原疫苗接种后诱导出强烈的Th1细胞因子模式。
J Infect Public Health. 2017 Jan-Feb;10(1):102-109. doi: 10.1016/j.jiph.2016.02.006. Epub 2016 Mar 23.
6
Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae.新型突变霍乱毒素佐剂mmCT的构建及其临床前评估,mmCT可在基因工程改造的霍乱弧菌中高效生产。
Vaccine. 2016 Apr 19;34(18):2121-8. doi: 10.1016/j.vaccine.2016.03.002. Epub 2016 Mar 11.
7
Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.缺氧导致的YAP核转位和激活有助于肝癌细胞对SN38产生化学抗性。
Oncotarget. 2016 Feb 9;7(6):6933-47. doi: 10.18632/oncotarget.6903.
8
Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines.智能外壳控制和靶向抗原释放以提高口服疫苗的适用性。
Biomaterials. 2016 Jan;77:307-19. doi: 10.1016/j.biomaterials.2015.11.009. Epub 2015 Nov 14.
9
Combinatorial Approach of Antigen Delivery Using M Cell-Homing Peptide and Mucoadhesive Vehicle to Enhance the Efficacy of Oral Vaccine.使用M细胞归巢肽和粘膜粘附载体进行抗原递送的组合方法以增强口服疫苗的效力
Mol Pharm. 2015 Nov 2;12(11):3816-28. doi: 10.1021/acs.molpharmaceut.5b00265. Epub 2015 Oct 2.
10
Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis.胃癌细胞中KPNβ1的上调促进肿瘤细胞增殖并预示不良预后。
Tumour Biol. 2016 Jan;37(1):661-72. doi: 10.1007/s13277-015-3839-7. Epub 2015 Aug 5.